Canadian investment firm Eat Beyond puts focus on Singapore, invests in two local startups

December 03, 2020
Consumer More...
by Thomas Hayes
Average importance

The firm invested in two cellular agriculture startups from Singapore: TurtleTree Labs and SingCell. The terms of the investments were not disclosed. The timing is uncanny, as Singapore just granted the world's first regulatory approval of cell-based meat. As Asia looks to tackle food security through novel food production methods, Singapore is becoming an innovation hotbed, especially for cellular agriculture. Clients, Singapore needs to be on the list for "where" to place bets in this space.

For the original news article, click here .

Further Reading

Future Meat Technologies adds another $26.75 million in funding to commercialize cell-based meat

News Commentary | February 12, 2021

This convertible note funding involved existing strategic investors as well as new investors like German dairy company Müller. The company has also managed to significantly bring down the costs of cell‑based chicken production. Looking to commercialize by 2022 upon regulatory approval, its first ... To read more, click here.

Singapore's Next Gen Foods raises $10 million seed round for scaling its plant-based chicken

News Commentary | February 26, 2021

This is reportedly the world's largest seed round in the plant‑based space. Investors include a mix of local ones (Temasek, K3 Ventures, and Singapore's Economic Development Board New Ventures) and foreign ones (i.e., German wholesaler Metro's NX‑Food). Next Gen will first be launching a chicken ... Not part of subscription

JBS agrees to acquire plant-based meat company Vivera for $410 million (€341 million)

News Commentary | April 23, 2021

Vivera is reportedly Europe's third‑largest plant‑based food company, with presence in 25 European countries. The acquisition includes Vivera's three manufacturing facilities and R&D center in the Netherlands. This is not JBS's first foray into the plant‑based space, as it launched its U.S. ... Not part of subscription